Mesoblast reaches 300-patient enrollment in back pain trial
Mesoblast reaches 300-patient enrollment in back pain trial
Mesoblast reaches 300-patient enrollment in back pain trial
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.